March 16, 2026 · Form 4 insider transaction
Davis George Eric bought 14,570 shares of BioMarin Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Restricted stock units granted March 16, 2026. Price not applicable.; The Reporting Person's direct holdings have been adjusted by thirteen shares to correct a previous clerical error.